Feds Arrest Telehealth Execs for Overprescribing Adderall
But will the government ever face repercussions for its role in the Adderall shortage?
But will the government ever face repercussions for its role in the Adderall shortage?
I'm the DEA's poster child for prescription stimulant abuse: a 30-something adult who needs a telehealth psychiatrist and can't remember what day the garbage truck comes.
The government still blames the private sector despite its own role in creating, exacerbating, and prolonging the shortage.
The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.
The change, while welcome, is modest and won't get rid of patients' headaches as they try to fill their prescriptions.
While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.
Each year, the DEA sets production limits for certain drugs, including some ingredients in common amphetamine pills like Adderall.
On Friday, the DEA unveiled a plan to restrict doctors' ability to prescribe controlled drugs over telehealth.
Limiting the supply of a controlled substance does not remove demand. Users simply look elsewhere, including more unsavory sources.